2014
DOI: 10.1371/journal.pone.0100261
|View full text |Cite
|
Sign up to set email alerts
|

Novel Mutations in BMPR2, ACVRL1 and KCNA5 Genes and Hemodynamic Parameters in Patients with Pulmonary Arterial Hypertension

Abstract: BackgroundPulmonary arterial hypertension (PAH) is a rare and progressive vascular disorder characterized by increased pulmonary vascular resistance and right heart failure. The aim of this study was to analyze the Bone Morphogenetic Protein Receptor 2 (BMPR2), Activin A type II receptor like kinase 1 (ALK1/ACVRL1) and potassium voltage-gated channel, shakerrelated subfamily, member 5 (KCNA5) genes in patients with idiopathic and associated PAH. Correlation among pathogenic mutations and clinical and functiona… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
50
0

Year Published

2015
2015
2022
2022

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 46 publications
(55 citation statements)
references
References 42 publications
0
50
0
Order By: Relevance
“…10, 22, 23 . In summary, 55 unrelated PAH patients of Spanish origin (28 IPAH, 18 APAH associated to connective tissue disease, 4 related to HIV and 5 porto-pulmonary hypertension) (Fig.…”
Section: Resultsmentioning
confidence: 99%
“…10, 22, 23 . In summary, 55 unrelated PAH patients of Spanish origin (28 IPAH, 18 APAH associated to connective tissue disease, 4 related to HIV and 5 porto-pulmonary hypertension) (Fig.…”
Section: Resultsmentioning
confidence: 99%
“…The Smad dimer then enters the nucleus where it acts as a transcription factor, regulating the transcription of angiogenesis genes such as VEGF. Reduced presence of endoglin, a coreceptor for ALK family of receptors, has been shown to decrease the activity of the ALK1 pathway, as well as the ALK5 pathway that counterbalances ALK1 activity by promoting cell c.24A > T Missense p.Lys8Ans [16] c.31_50del20 Deletion p.Leu11Glyfs*20 [17] c.37delC Deletion p.Leu13Cysfs*2 [18] c.50dupT Duplication p.Leu17Phefs*21 [19] c.50_53delTGGT Deletion p.Leu*17 [20] c.61 + 1G > A Missense p.? [14] c.61 + 10G > A Splice Site p.?…”
Section: Discussionmentioning
confidence: 99%
“…[39] c.626-3C > G Splice Site p.? [55] c.632G > A Missense p.Gly211Asp [51] c.639T > G Missense p.Tyr213* [14] c.641delG Deletion p.Gly214Alafs*44 [45] c.643G > A Missense p.Glu215Lys [31] c.647T > G Missense p.Val216Gly [19] c.649T > G Missense p.Trp217Gly [45] c.650G > A Missense p.Trp217* [20] c.651G > A Missense p.Trp217* [24] c.653_654delGGinsCC Delins p.Arg218Pro [52] c.656G > A Missense p.Gly219Asp [24] c.661T > G Missense p.Trp221Gly [14] c.662G > A Missense p.Trp221* [19] c.663G > A Missense p.Trp221* [47] c.664_668delCACGG Deletion p.His222* [31] Continued c.667G > C Missense p.Gly223Arg [31] c.670G > A Missense p.Glu224Lys [25] c.673A > T Missense p.Ser225Cys [16] c.673_674delAG Deletion p.Ser225Cysfs*11 [47] c.676G > C Missense p.Val226Leu [30] c.677T > A Missense p.Val226Glu [45] c.682delG Deletion p.Val228Serfs*30 [31] c.683T > A Missense p.Val228Asp [19] c.686A > T Missense p.Lys229Met [55] c.686A > G Missense p.Lys229Arg [31] c.696_698delCTC Deletion p.Ser233del [56] c.698C > T Missense p.Ser233Leu [37] c.698C > A Missense p.Ser233* [57] c.704delA Deletion p.Asp235Valfs*23 [31] c.709C > T Missense p.Gln237* [25] c.716G > A Missense p.Trp239* [46] c.743_744delCA Deletion p.Thr248Serfs*143 [29] c.760_762delGAC Deletion p.Asp254del [18] c.759_761delCGA Deletion p.Asp254del [31] c.772 + 3_772 + 4dupAA Duplication p.? [43] c.772 + 5G > A Missense p.?…”
Section: Discussionmentioning
confidence: 99%
“…45 Patients carrying a mutation in the BMPR2, ALK1 and KCNA5 genes had a higher value of mean pulmonary pressure and pulmonary vascular resistance, and a significantly lower cardiac index than non-carriers. 47 An imbalance of increased TGF-b levels and decreased BMP signals induced by BMPR2 mutations leads to PAH. 48 The p.(S225C) mutation is located in exon 6 of ALK1 gene and it is placed in the serineethreonine kinase domain.…”
Section: Clinical Significancementioning
confidence: 99%